本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Monte Rosa Therapeutics

4.64
+0.18004.04%
成交量:12.66萬
成交額:58.28萬
市值:2.85億
市盈率:-4.72
高:4.74
開:4.52
低:4.51
收:4.46
資料載入中...
2024/05/13

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/02

重要事件披露

Form 8-K - Current report
2024/05/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/14

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/14

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/14

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2023/11/10

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/26

重要事件披露

Form 8-K - Current report
2023/10/17

重要事件披露

Form 8-K - Current report
2023/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]